Autoimmune Disease Therapeutics Market to reach a market size of $149.4 billion by 2025


Newslookup.com: kbvresearch | 2019-09-23 13:11 UTC

According to a new report Global Autoimmune Disease Therapeutics Market, published by KBV Research, The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period.

The North America market dominated the Global Multiple Sclerosis Market by Region in 2018, growing at a CAGR of 3.9 % during the forecast period. The Europe market is expected to witness a CAGR of 4.1% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 5.9% during (2019-2025).

The Anti-Inflammatory market would dominate the Global Autoimmune Disease Therapeutics Market by Drug Class by 2025growing at a CAGR of 4.5 % during the forecast period. The Anti-Hyperglycemics market is expected to witness a CAGR of 4.7% during (2019-2025).

The Retail Pharmacies and Drug Stores market dominated the Global Autoimmune Disease Therapeutics Market by Distribution Channel in 2018, growing at a CAGR of 4.2 % during the forecast period. The Online market is expected to witness a CAGR of 4.6% during (2019-2025).

Full Report: https://www.kbvresearch.com/autoimmune-disease-therapeutics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Global Autoimmune Disease Therapeutics Market Segmentation

By Indication

Rheumatic Disease
Diabetes
Multiple Sclerosis
Inflammatory Bowel Disease
Other Indications

By Drug Class

Anti-Inflammatory
Anti-Hyperglycemics
NSAIDs
Interferons
Other Drugs

By Distribution Channel

Hospital Pharmacy
Online
Retail Pharmacies and Drug Stores

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

ABBOTT Laboratories
Bio-Rad Laboratories, Inc.
Johnson and Johnson
GlaxoSmithKline PLC (GSK)
Pfizer, Inc.
Merck and Co., Inc.
Bayer AG
AbbVie, Inc.
Amgen, Inc.
Novartis AG

Autoimmune Disease Therapeutics Market Related Reports:

North America Market
Europe Market
Asia Pacific Market
LAMEA Market

By kbvresearch on 2019-09-23 13:11 UTC
  • Need an account?  
    or